Paper1967337
Metolazone in treatment of severe refractory congestive cardiac failure.
Kiyingi A and 5 others. Lancet, 1990. Cited by 70 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Metolazone in treatment of severe refractory congestive cardiac failure. Papers, record 1967337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1967337
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diuretics | Major topic |
| Heart Failure | Major topic |
| Metolazone | Major topic |
| Aged | |
| Aged, 80 and over | |
| Body Weight | |
| Clinical Trials as Topic | |
| Diuresis | |
| Dobutamine | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Middle Aged | |
| Prognosis |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 1,970,014 | Thiazides with loop diuretics for severe congestive heart failure. | https://conductscience.org/library/papers/1970014 | PubMed |
| Comment in | 1,970,077 | Metolazone for severe dilated cardiomyopathy refractory to conventional therapy. | https://conductscience.org/library/papers/1970077 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,425,090 | Proximal versus distal diuretics in congestive heart failure. | Nephrol Dial Transplant | 2024 | https://conductscience.org/library/papers/38425090 | PubMed |
| 36,254,331 | Cardiorenal Interactions: A Review. | CJC Open | 2022 | https://conductscience.org/library/papers/36254331 | PubMed |
| 31,762,481 | Oral Metolazone Versus Intravenous Chlorothiazide as an Adjunct to Loop Diuretics for Diuresis in Acute Decompensated Heart Failure With Reduced Ejection Fraction. | Hosp Pharm | 2019 | https://conductscience.org/library/papers/31762481 | PubMed |
| 31,300,181 | Cardiorenal Syndrome and Heart Failure-Challenges and Opportunities. | Can J Cardiol | 2019 | https://conductscience.org/library/papers/31300181 | PubMed |
| 30,371,181 | Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. | J Am Heart Assoc | 2018 | https://conductscience.org/library/papers/30371181 | PubMed |
| 28,728,476 | A perspective on diuretic resistance in chronic congestive heart failure. | Ther Adv Cardiovasc Dis | 2017 | https://conductscience.org/library/papers/28728476 | PubMed |
| 27,056,656 | Decongestion: Diuretics and other therapies for hospitalized heart failure. | Indian Heart J | 2016 | https://conductscience.org/library/papers/27056656 | PubMed |
| 22,586,787 | Intravenous diuretic day-care treatment for patients with heart failure. | Clin Med (Lond) | 2012 | https://conductscience.org/library/papers/22586787 | PubMed |
| 22,408,719 | The Synthesis and Evaluation of Dihydroquinazolin-4-ones and Quinazolin-4-ones as Thyroid Stimulating Hormone Receptor Agonists. | Medchemcomm | 2011 | https://conductscience.org/library/papers/22408719 | PubMed |
| 20,069,075 | Acute decompensated heart failure: contemporary medical management. | Tex Heart Inst J | 2009 | https://conductscience.org/library/papers/20069075 | PubMed |
| 17,245,481 | Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. | Can J Cardiol | 2007 | https://conductscience.org/library/papers/17245481 | PubMed |
| 16,684,496 | Diuretic resistance in heart failure. | Curr Heart Fail Rep | 2006 | https://conductscience.org/library/papers/16684496 | PubMed |
| 15,809,817 | The cardiorenal syndrome: lessons from the ADHERE database and treatment options. | Heart Fail Rev | 2004 | https://conductscience.org/library/papers/15809817 | PubMed |
| 15,082,840 | Use of diuretics in cardiovascular diseases: (1) heart failure. | Postgrad Med J | 2004 | https://conductscience.org/library/papers/15082840 | PubMed |
| 12,782,772 | Mechanisms and management of diuretic resistance in congestive heart failure. | Postgrad Med J | 2003 | https://conductscience.org/library/papers/12782772 | PubMed |
| 10,755,326 | Optimising management of patients with advanced heart failure: the importance of preventing progression. | Drugs Aging | 2000 | https://conductscience.org/library/papers/10755326 | PubMed |
| 9,506,239 | Combination diuretic therapy in severe congestive heart failure. | Drugs | 1998 | https://conductscience.org/library/papers/9506239 | PubMed |
| 8,882,374 | Novel drugs and current therapeutic approaches in the treatment of heart failure. | Drugs | 1996 | https://conductscience.org/library/papers/8882374 | PubMed |
| 8,882,303 | Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8882303 | PubMed |
| 8,130,022 | Combination diuretic treatment in severe heart failure: a randomised controlled trial. | Br Heart J | 1994 | https://conductscience.org/library/papers/8130022 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1967337
GET https://conductscience.org/api/papers/v1/1967337/cited_by?page=2